we studied fasting proinsulin levels and proinsulin/c-peptide ratios in the newly diagnosed diabetic subjects participating in the canadian/european placebo controlled cyclosporin study at entry , during the one year treatment period and six months of follow-up .
C0033362
proinsulin
C0006558
proinsulin/c-peptide